ACG Postgraduate Course at 2024 Annual Meeting

• Peri-Procedural Management of Antithrombotic Agents: How to Minimize Unintended Bleeding and Clotting
  Neena S. Abraham, MD, MSc (Epid), MACG
  Describe the classes of antithrombotic agents and recognize when to continue, when to stop, and when to restart antithrombotic agents for GI procedures.
• Non-Variceal Upper GI Bleeding: Inject, Cauterize, Clip, or Spray?
  Loren A. Laine, MD, FACG
  Provide the latest recommendations on the pre-endoscopic and endoscopic management of non-variceal upper GI bleeds.
• Small Bowel Bleeding: How to Locate, Treat, and Improve Quality of Care
  Jonathan A. Leighton, MD, FACG
  Explain the diagnostic and therapeutic approach to patients with small bowel bleeding, with a focus on quality metrics in the performance of video capsule endoscopy and deep enteroscopy.
• Lower GI Bleeding: Tips for Optimal Localization and Treatment
  Neil Sengupta, MD, FACG
  Explain ways to improve the medical, endoscopic, and radiologic diagnosis and management of patients with lower GI bleeding.
• Panel Q & A

Creating a Manageable Cockpit for Physicians
Christine A. Sinsky, MD, MACP
Discuss the science supporting the quality, safety, and business cases for focusing on creating a “manageable cockpit” and describe practical leadership, workflow, and teamwork interventions that can improve professional satisfaction and reduce burnout.

• Alcohol-Associated Liver Disease: Recommendations From the Guidelines
  Vijay H. Shah, MD, FACG
  Provide the latest management recommendations for alcohol-associated liver disease based on the recent ACG guidelines.
• Making Sense of the Alphabet Soup: Updates in Non-Hepatitis C Viral Hepatidities
  Paul Martin, MD, FACG
  Review recent developments in the diagnosis and treatment of hepatitis A, B, D, and E.
• Managing Complications of Cirrhosis
  Jasmohan S. Bajaj, MD, MS, FACG
  Outline the management of variceal bleeding, ascites, encephalopathy, and hepatocellular carcinoma in patients with cirrhosis.
• Optimizing Outcomes in Acute and Acute-on-Chronic Liver Failure
  Atoosa Rabiee, MD
  Define acute and acute-on-chronic liver failure and recognize strategies to improve patient outcomes and discuss when to refer for transplant evaluation.
• Panel Q & A

Saturday Optional Learning Luncheon Bonus Sessions

ACG has combined the popular in-person Learning Luncheons with on-demand access to the pre-recorded lectures for ALL 24 Learning Luncheon Bonus Sessions. Add this optional package to your Postgraduate Course registration for even more first-class education that provides an additional 18 hours of CME/MOC credit!

You must register for the Postgraduate Course in order to purchase the optional Learning Luncheon Bonus Sessions package. Both in-person and virtual registrants can purchase this add-on package. In-person attendees purchasing the package will be able to select a Saturday and a Sunday luncheon presentation to attend during the registration process.

1. Hepatitis C: Far From Over
   Paul Y. Kwo, MD, FACG
   Provide an overview of screening recommendations, updates in treatment options, and long-term surveillance of patients with hepatitis C.
2. Perfecting Your Clinical Consult: Reflections From a Master Clinician
   Lawrence J. Brandt, MD, MACG
   Identify ways to improve effective patient and provider communication and optimize the diagnostic evaluation.
3. Autoimmune Enteropathy and Eosinophilic Enteritis
   Dejan Micic, MD, FACG
   Illustrate the clinical presentation, evaluation, and treatment of eosinophilic gastrointestinal disorders based on current evidence.
4. Hereditary GI Cancers and Gastrointestinal Polyposis Syndromes: Who to Screen, How to Surveil, and What Resources Are Available
   Carol A. Burke, MD, FACG
   Explore the screening and surveillance recommendations of patients with hereditary GI cancer and polyposis syndromes.
5. Management of an Ileal Pouch: From Symptoms to Cancer Surveillance
   Maia Kayal, MD, MS
   Define symptoms of ileal pouch dysfunction and provide surveillance and management recommendations.
6. Evaluation and Management of Benign Anorectal Disorders
   Satish S. C. Rao, MD, PhD, FACG
   Recognize symptoms and signs of common benign anorectal disorders and the associated diagnostic work-up and management.
7. Keeping You Out of Trouble When Endoscopic Complications Happen
   Shivangi T. Kothari, MD, FACG
   Provide strategies for the effective management of post-procedural complications with a focus on recognition, endoscopic treatment options, team approach, documentation, and communication.
8. Role of Diet in the Management of IBD
   Linda A. Feagins, MD, FACG
   Compare and contrast the various dietary options for patients with IBD with a focus on therapeutic benefits.
9. Introduction to the GI Hospitalist Program
   Michelle L. Hughes, MD
   Explain the concept, benefits, disadvantages, and practice structure of a GI hospitalist model.
10. Drug-Induced Liver Injury: How to Diagnose and Prevent
    Norah A. Terrault, MD, MPH, FACG
    Explain the diagnostic approach to patients with suspected drug-induced liver injury, associated treatments when available, and resources available to providers.
11. Healthcare Maintenance in IBD
    Anita Afzali, MD, MPH, MHCM, FACG
    Provide recommendations on preventive care, surveillance, and management of comorbidities in patients with IBD.
12. All You Ever Wanted to Know About Dyspepsia and Eructation
    Baharak Moshiree, MD, MSc, FACG
    Define dyspepsia and eructation and review the diagnostic work-up and available therapies to improve the lives of both your patient and you.

Symposium A: Battling the Bulge: From Metabolic-Associated Liver Disease to Obesity: What’s in My Clinical and Endoscopic Toolbox?
Moderator: Linda Anh B. Nguyen, MD, FACG

• Medical Therapies for Obesity and Their GI Side Effects
  Linda Anh B. Nguyen, MD, FACG
  Compare the different types, mechanisms of action, efficacy, and potential side effects of weight loss medications on the GI tract.
• Metabolic Dysfunction-Associated Steatotic Liver Disease: Causes, Prevention, and Treatment
  Nancy S. Reau, MD, FACG
  Explain the new classification of metabolic-associated fatty liver disease and describe management strategies focusing on comorbidities and currently available medical therapies.
• Bariatric Endoscopy: What’s New?
  Reem Z. Sharaiha, MD, MSc
  Explore the types of endoscopic bariatric procedures, their indications, contraindications, and applications.
• Panel Q & A

Symposium B: Incidentalomas: What to Do With Unexpected Findings
Moderator: Vanessa M. Shami, MD, FACG

• Submucosal Lesions of the GI Tract
  Vanessa M. Shami, MD, FACG
  Classify different types of submucosal lesions found during endoscopy and explain the diagnostic and therapeutic approaches.
• Evaluation and Management of Biliary Strictures
  Vivek Kaul, MD, FACG
  Differentiate the types of biliary strictures and the diagnostic and therapeutic evaluation, intervention, and surveillance of these lesions.
• Focal Liver Lesions: An Imaging Primer From the Guidelines
  Anjana A. Pillai, MD, FACG
  Explain the different subtypes of liver lesions and their management.
• Panel Q & A

Symposium C: Evaluation and Management of Disorders of the Gut-Brain Axis
Moderator: William D. Chey, MD, FACG

• Evaluation and Management of Chronic Abdominal Pain and Suspected IBS
  Jill K. Deutsch, MD, MA
  Differentiate organic from functional chronic abdominal pain and explore the medical and complementary therapies available.
• Constipation: Pharmacologic and Non-Pharmacologic Therapies
  William D. Chey, MD, FACG
  Outline the types of medications and other modalities, including dietary and lifestyle modifications, for treatment of constipation.
• Functional Diarrhea: What’s in My Toolbox?
  Brian E. Lacy, MD, PhD, FACG
  Describe the therapeutic options available for functional diarrhea, including medications, dietary manipulations, and lifestyle interventions.
• Panel Q & A

• Management of Acute Pancreatitis: Updates From the Guidelines
  Santhi Swaroop Vege, MD, MACG
  Provide the most recent recommendations for optimal care of patients with acute pancreatitis based on the recent ACG guidelines.
• Chronic Pancreatitis: Managing Pain, Exocrine, and Endocrine Dysfunction
  Jodie A. Barkin, MD, FACG
  Explain the manifestations and complications of chronic pancreatitis, their epidemiology, and optimal management strategies.
• Pancreatic Cysts: Drain it, Surveil it, or Leave it Alone?
  Anne Marie Lennon, MD, PhD, FACG
  Differentiate pancreatic cyst subtypes and explore which cysts require diagnostic work-up, therapeutic intervention, or surveillance.
• Panel Q & A